[Consensus diagnosis and therapy of soft tissue sarcoma].
Soft tissue sarcomas are heterogeneous tumours and relatively uncommon. There have been advances over the past years concerning pathology, clinical behaviour, diagnosis strategies and the treatment. To summarize these advances as well as making it public is one of the goals of the following consensus guidelines. But why do we need special guidelines for Austria? There are international guidelines published by the European Society of Medical Oncology (ESMO) and the National Comprehensive Cancer Network (NCCN). The cause is that we need an explanation of the matrix the ESMO and the NCCN gave according to our clinical practice, the local requirements and facilities in Austria. The following recommendations were drawn up following a consensus meeting of sarcoma specialists from the three high volume centres located at the medical universities in Austria. All fields of involved physicians from diagnosis to therapy worked together to know that soft tissue sarcomas are an interdisciplinary challenge and multimodal treatment is essential. For this reason, these guidelines not only explain but also give the state of the art and clear recommendations. One of the most important guidelines is that any patient with a suspected soft tissue sarcoma should be referred to one of the three university centres and managed by a specialist sarcoma multidisciplinary team. We hope that the consensus is helpful for the clinical practice and improves the quality of care for patients with soft tissue sarcomas in Austria.
Klinische Abteilung für Onkologie, Universitätsklinik für Innere Medizin, Wien, Austria. Thomas.brodowicz@meduniwien.ac.at
Thomas
T
Brodowicz
Gabriele
G
Amann
Andreas
A
Leithner
Arpad
A
Sztankay
Franz
F
Kainberger
Wolfgang
W
Eisterer
Bernadette
B
Liegl-Atzwanger
Franz
F
Rachbauer
Thomas
T
Rath
Michael
M
Bergmann
Philipp T
PT
Funovics
Ferdinand
F
Ploner
Reinhard
R
Windhager
D001317:Austria; D006801:Humans; D008495:Medical Oncology / Q000592:standards*; D017410:Practice Guidelines as Topic; D012509:Sarcoma / Q000175:diagnosis* / Q000628:therapy*